Saroja Pharma Industries was incorporated with the objective of the best service deliverance in chemical trading with the best premium pharmaceutical companies in India and abroad for cost-effective human and veterinary medicine. The Company trades in Pharma API, Pharma Intermediates, Chemicals, and Solvents used for pharmaceutical products and human and veterinary medicine. The Company was formed with a mission being providing clientele with specification based approved products at competitive pricing with hassle-free dispatch within India or aboard contributing to cost effectiveness in end products for human and veterinary medicine.
They are into Active Pharmaceuticals Ingredients, Specialty Chemicals, Intermediates for Pharma trading. They are also into specialty chemicals imports & exports as well as supply of the same to the actual users. As per the clients needs and requirements, they provide customized specialty chemicals in India and abroad regularly. Saroja Pharma Specialty chemicals & its intermediates have wide application in sectors like pharma, agro & chemicals for human and veterinary.
Since its inception, Saroja Pharma Industries India Limited has witnessed a substantial expansion in its clientele base over the past two years. This growth has propelled the company to venture into the manufacturing of API Pharma products, for veterinary use. By broadening its product portfolio, Saroja Pharma Industries India Limited aims to provide a comprehensive range of pharmaceutical solutions that cater to the diverse needs of its expanding customer base. This strategic move not only enhances the company’s value proposition but also reinforces its commitment to delivering affordable healthcare solutions globally.
Objects of the Issue:
- To Set-up a Manufacturing Unit.
- To Repay the Unsecured Loans.
- Public Issue Expenses.
Saroja Pharma IPO Review
- Avoid
Saroja Pharma IPO Date & Price Band Details
| IPO Open: | August 31, 2023 |
| IPO Close: | September 5, 2023 |
| IPO Size: | Approx ₹9.11 Crores, 1,084,800 Equity Shares |
| Face Value: | ₹10 Per Equity Share |
| IPO Price Band: | ₹84 Per Equity Share |
| IPO Listing on: | NSE SME |
| Retail Quota: | 50% of the net offer |
| NII Quota: | 50% of the net offer |
| DRHP Draft Prospectus: | Click Here |
| RHP Draft Prospectus: | Click Here |
| Anchor Investors in IPO: | Click Here |
Saroja Pharma IPO Market Lot
The Saroja Pharma IPO minimum market lot is 1600 shares with a ₹134,400 application amount.
| Application | Lot Size | Shares | Amount |
| Retail Minimum | 1 | 1600 | ₹134,400 |
| Retail Maximum | 1 | 1600 | ₹134,400 |
| S-HNI Minimum | 2 | 3200 | ₹268,800 |
Saroja Pharma IPO Dates
The Saroja Pharma IPO date is August 31 and the IPO close date is September 5. The IPO allotment date is September 8 and the IPO might list on September 13.
| IPO Open Date: | August 31, 2023 |
| IPO Close Date: | September 5, 2023 |
| Basis of Allotment: | September 8, 2023 |
| Refunds: | September 11, 2023 |
| Credit to Demat Account: | September 12, 2023 |
| IPO Listing Date: | September 13, 2023 |
You can check IPO subscription status and IPO allotment status on their respective pages.
Saroja Pharma IPO Form
How to apply Saroja Pharma IPO? You can apply Saroja Pharma IPO via ASBA available in your bank account. Just go to the online bank login and apply via your bank account by selecting the Saroja Pharma IPO in the Invest section. The other option you can apply Saroja Pharma IPO via IPO forms download via the NSE website. Check out the Saroja Pharma forms – click NSE IPO Forms download, fill and submit in your bank or with your broker.
Saroja Pharma Company Financial Report
| ₹ in Crores | |||
| Year | Revenue | Expense | PAT |
| 2021 | ₹36.75 | ₹35.71 | ₹0.73 |
| 2022 | ₹55.96 | ₹54.38 | ₹1.14 |
| 2023 | ₹50.35 | ₹48.86 | ₹1.06 |
Saroja Pharma IPO Valuation – FY2023
Check Saroja Pharma IPO valuations detail like Earning Per Share (EPS), Price/Earning P/E Ratio, Return on Net Worth (RoNW), and Net Asset Value (NAV) details.
| Earning Per Share (EPS): | ₹3.61 per Equity Share |
| Price/Earning P/E Ratio: | 3.61 |
| Return on Net Worth (RoNW): | 20.85% |
| Net Asset Value (NAV): | ₹17.33 per Equity Share |
Peer Group
- NGL Fine Chem Limited
- Sequent Scientific Limited
Company Promoters
- Mr. Biju Gopinathan Nair
- Mr. Manish Dasharath Kamble
Saroja Pharma IPO Registrar
Kfin Technologies Limited
Phone: 04067162222, 04079611000
Email: [email protected]
Website: https://kosmic.kfintech.com/
Saroja Pharma IPO Allotment Status
Check Saroja Pharma IPO allotment status on Kfin Technologies website URL. Click Her
Saroja Pharma IPO Lead Managers aka Merchant Bankers
- Swastika Investmart Ltd
Company Address
Saroja Pharma Industries India Limited
305, Kailash Tower, Shiv Shristi Complex,
Goregaon Link Road, Mulund West,
Mumbai (MH) – 400080
Phone: +91 (022) 2081 0011
Email: [email protected]
Website: https://www.sarojapharma.com/
Saroja Pharma IPO FAQs
What is Saroja Pharma IPO?
When Saroja Pharma IPO will open?
What is Saroja Pharma IPO Investors Portion?
How to Apply the Saroja Pharma IPO?
How to Apply the Saroja Pharma IPO through Zerodha?
How to Apply the Saroja Pharma IPO through Upstox?
How to Apply the Saroja Pharma IPO through Paytm Money?
What is Saroja Pharma IPO Size?
What is Saroja Pharma IPO Price Band?
What is Saroja Pharma IPO Minimum and Maximum Lot Size?
What is Saroja Pharma IPO Allotment Date?
What is Saroja Pharma IPO Listing Date?
Follow IPO Watch for the upcoming IPO news and their reviews, also keep following us on Twitter, Facebook, and Instagram. For our latest videos, subscribe to our YouTube channel.
